Orphan Drug Designation For Remdesivir Is 'Consistent' With Precedent, Former FDA Lawyer Says

Vaccine bottle design related to viruses cures. Illustration design medical healing.
Gilead's remdesivir receives orphan drug designation for COVID-19
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership